Current Cancer Therapy Reviews
Title:Meet Our Editorial Board Member
Volume: 14 Issue: 2
Author(s): Ronald M. Bukowski
Affiliation:
Export Options
About this article
Cite this article as:
Bukowski M. Ronald , Meet Our Editorial Board Member, Current Cancer Therapy Reviews 2018; 14 (2) . https://dx.doi.org/10.2174/157339471402180712111844
DOI https://dx.doi.org/10.2174/157339471402180712111844 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Mitochondria and Familial Predisposition to Breast Cancer
Current Genomics MicroRNAs-based Therapy: A Novel and Promising Strategy for Cancer Treatment
MicroRNA Star Graphs of Protein Sequences and Proteome Mass Spectra in Cancer Prediction
Current Proteomics Polymer Membrane and Cell Models for Drug Discovery
Combinatorial Chemistry & High Throughput Screening New Histopathological & Genetic Features to Improve Active Surveillance Selection for Low-Risk Prostate Cancer
Anti-Cancer Agents in Medicinal Chemistry Synthesis, Biochemical Evaluation and Rationalisation of the Inhibitory Activity of a Range of Derivatives of 2-imidazol-1-yl-1-phenyl-ethanone as Potential Novel Inhibitors of 17α-hydroxylase/17,20-lyase (P-45017α)
Letters in Drug Design & Discovery Novel Colchicine Derivatives and their Anti-cancer Activity
Current Topics in Medicinal Chemistry Antiangiogenic Therapy
Current Pharmaceutical Design (6-Bromo-1,4-dimethyl-9<i>H</i>-carbazol-3-yl-methylene)-hydrazine (Carbhydraz) Acts as a GPER Agonist in Breast Cancer Cells
Current Topics in Medicinal Chemistry HCV-targeted Antivirals: Current Status and Future Challenges
Current Pharmaceutical Design FAK and Nanog Cross Talk with p53 in Cancer Stem Cells
Anti-Cancer Agents in Medicinal Chemistry Non-Invasive Ventilation in Stable Chronic Obstructive Pulmonary Disease
Current Respiratory Medicine Reviews Targeting of Low-Molecular Weight Drugs to Mammalian Mitochondria
Drug Design Reviews - Online (Discontinued) The Effects of Weightlessness on the Human Organism and Mammalian Cells
Current Molecular Medicine Design Graph Theoretical Analysis and In Silico Modeling of Dunaliella Bardawil Biomass Encapsulated N-Succinyl Chitosan Nanoparticles for Enhanced Anticancer Activity
Anti-Cancer Agents in Medicinal Chemistry PDE5 Inhibitors Offer Novel Mechanisms in Combination and Solo Cancer Therapy
Current Cancer Therapy Reviews Breast Cancer: Current Molecular Therapeutic Targets and New Players
Anti-Cancer Agents in Medicinal Chemistry Formulation, Pharmacokinetic Evaluation and Cytotoxicity of an Enhanced- penetration Paclitaxel Nanosuspension
Current Cancer Drug Targets Targeting Soluble Epoxide Hydrolase for Inflammation and Pain - An Overview of Pharmacology and the Inhibitors
Inflammation & Allergy - Drug Targets (Discontinued) HLA Class I Expression, Tumor Escape and Cancer Progression
Current Cancer Therapy Reviews